Brief: Aardvark Therapeutics Announces Establishment Of New U.S. Subsidiary
12/02/2026 14:40
Feb 12 (Reuters) - Aardvark Therapeutics Inc AARD.O: AARDVARK THERAPEUTICS ANNOUNCES ESTABLISHMENT OF NEW U.S. SUBSIDIARY TO SUPPORT DEVELOPMENT OF ITS DERMATOLOGY PIPELINE; BRYAN JONES NAMED CHIEF EXECUTIVE OFFICER Source text: ID:nGNX4C5rg4 Further company coverage: AARD.O ((Reuters.Briefs@thomsonreuters.com;))